π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This phase I trial studies how well atezolizumab before and/or with standar...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-07
Trial ID
NCT03738228
Treatments Being Tested
This pilot clinical trial studies the side effects and the best way to give...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2009-02-25
Trial ID
NCT00867178
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This phase I trial is studying the side effects and best dose of gefitinib ...
Status
Terminated
Location
University of Colorado
Start Date
2002-02
Trial ID
NCT00033449
Treatments Being Tested
Non-resectable stage III non-small cell lung cancer is recommended for conc...
Status
Unknown
Location
Affiliated Hospital of Guizhou Medical University
Start Date
2019-09-01
Trial ID
NCT04284215
Treatments Being Tested
This clinical trial studies how well intensity modulated proton therapy (IM...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-02-16
Trial ID
NCT05075980
This randomized phase II trial studies cisplatin and etoposide to see how w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2009-07-16
Trial ID
NCT00887159
Treatments Being Tested
Nasopharyngeal carcinoma (NPC) has a low incidence rate in children, accoun...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-17
Trial ID
NCT06605131
Treatments Being Tested
This phase III trial studies how well chemotherapy and radiation therapy (c...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-26
Trial ID
NCT03811002
RATIONALE: Fosaprepitant dimeglumine, palonosetron hydrochloride, and dexam...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2009-02
Trial ID
NCT00895245